TP53 and KRAS were also identified as the significantly mutated genes in a cohort of ICC patients and Ras/PI3K signaling was one of the most affected pathways, followed by cell cycle signaling pathway [22]. The gene discussed is KRAS; the disease is intrahepatic cholangiocarcinoma.